as on February 6, 2026 at 2:29 am IST
Day's Low
Day's High
1.60%
Downside
7.63%
Upside
52 Week's Low
52 Week's High
81.36%
Downside
74.99%
Upside
Check Capricor Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.3B
EPS (TTM)
-2.1586
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-84.9M
Revenue (TTM)
11.1M
Profit Margin
0.00%
Return On Equity TTM
-107.79%
Compare market cap, revenue, PE, and other key metrics of Capricor Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.3B | 237.68% | NA | 0.00% | |
| BUY | $47.7B | 100.62% | 1246.03 | 1.36% | |
| BUY | $122.3B | 113.14% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 53.64% | 18.28 | 32.13% |
The Capricor Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Capricor Therapeutics Inc investment value today
Current value as on today
₹1,64,359
Returns
₹64,359
(+64.36%)
Returns from Capricor Therapeutics Inc Stock
₹60,991 (+60.99%)
Dollar Returns*
₹3,368 (+3.37%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Capricor Therapeutics Inc. Average target price of $50.8
Get share price movements and forecasts by analysts on Capricor Therapeutics Inc.
What analysts predicted
54.59%UPSIDE
Target Price
$50.8
Current Price
$23.07
Analyzed by
10 Analysts
Target
$50.80
Capricor Therapeutics Inc target price $50.8, a slight upside of 54.59% compared to current price of $23.07. According to 10 analysts rating.
Search interest for Capricor Therapeutics Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 January
Wed, 04:41 PM
-Capricor updates on Deramiocel BLA; FDA requests full HOPE-3 study report, no new trials needed.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, CAPR has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
![]()
In the last 1 year, CAPR has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -25.91M → -24.57M (in $), with an average increase of 5.5% per quarter
Price Rise
![]()
In the last 3 months, CAPR stock has moved up by 290.1%
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 2.26M → 11.13M (in $), with an average increase of 79.7% per quarter
| Organisation | Capricor Therapeutics Inc |
| Headquarters | 10865 Road to the Cure, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Dr. Linda Marbán Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Frank Isaac Litvack FACC, M.D. | Executive Chairman of the Board |
Ms. Karen G. Krasney Esq., J.D. | Executive VP, General Counsel & Secretary |
Mr. Minghao Sun Ph.D. | Senior Vice President of Quality Control, Research & Product Development |
Mr. Mark Awadalla | Chief Development Officer |
Nathaniel Hogan Ph.D. | Director of Biostatistics of Capricor Therapeutics |
Dr. Linda Marbán Ph.D. | Co-Founder, President, CEO & Director |
Mr. Anthony J. Bergmann M.B.A. | CFO & Corporate Treasurer |
Dr. Kristi A. H. Elliott Ph.D. | Chief Operating & Science Officer |
Dr. Micheal Binks M.D. | Chief Medical Officer |
Catherine Lee Kelleher M.D. | Consultant |
Capricor Therapeutics Inc share price today is $23.07 as on at the close of the market. Capricor Therapeutics Inc share today touched a day high of $24.83 and a low of $22.7.
Capricor Therapeutics Inc share touched a 52 week high of $40.37 on and a 52 week low of $4.3 on . Capricor Therapeutics Inc stock price today i.e. is closed at $23.07,which is 42.85% down from its 52 week high and 436.51% up from its 52 week low.
Capricor Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Capricor Therapeutics Inc (CAPR) shares with as little as ₹90.283 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.83 in Capricor Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Capricor Therapeutics Inc share’s latest price of $23.07 as on February 6, 2026 at 2:29 am IST, you will get 0.4335 shares of Capricor Therapeutics Inc. Learn more about
fractional shares .
Capricor Therapeutics Inc stock has given 237.68% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?